novo glp-1 drug Nordisk plans to slash prices Trump low-cost GLP-1 plan a

These results established tirzepatide as the most potent agent in the current pharmacologic armamentarium for obesity

Expert Opinion GLP-1 receptor agonists, along with dual and triple agonists, have transformed the landscape of adolescent obesity treatment, offering an effective alternative to lifestyle interventions that often fail to produce long-term results

Obesity (2022)

Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors

For people seeking a pill-based, research-backed route rather than injectables, Motus can be a useful conversation to have with your clinician

Plainsboro, NJ